This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Veterinary Pain Management Drugs Market

Market Insights on Veterinary Pain Management Drugs covering sales outlook, demand forecast & up-to-date key trends

Veterinary Pain Management Drugs Market: Global Industry Analysis and Opportunity Assessment 2016-2026

Veterinary Pain Management Drugs Market Overview

The market for Veterinary Pain Management Drugs was worth US$ 1.37 billion in 2022 and is predicted to be worth US$ 2.79 billion by 2032, growing at a 7.2% CAGR from 2022 to 2032.

Report Attribute


Veterinary Pain Management Drugs Market Value (2022)

US$ 1.37 Bn

Veterinary Pain Management Drugs Market Anticipated Value (2032)

US$ 2.79 Bn

Veterinary Pain Management Drugs Market Growth Rate (2022 to 2032)

7.2% CAGR

Customize this Report

Let us know your requirement to get
100% FREE customization

Veterinary Pain Management Drugs Market Drivers

The global veterinary pain management medicines market is being pushed by factors such as the rising prevalence of painful and inflammatory disorders in animals, increased animal healthcare initiatives, and an increase in the number of companion animal owners.

During the projected period, the increasing government initiative toward animal healthcare is expected to drive the veterinary pain management pharmaceuticals market.

Veterinary Pain Management Drugs Market Restraints

Changes in distribution channels are expected to stymie market expansion.

Companion animal owners typically purchase animal health items from veterinarians. Owners of companion animals have adjusted their purchasing habits, shifting their focus to internet-based retailers, retail stores, or other over-the-counter distribution channels. This change is causing companion health owners to choose human health products instead of animal health products if human health products are regarded to be less expensive alternatives.

Furthermore, consolidation of primary consumers such as veterinarians may have a negative impact on the price of companion healthcare items. Furthermore, the rising use of low-cost generic product subtitles may limit market potential. Regulators' restrictions may have a negative influence on the sales of pain relievers. Increasing costs of companion healthcare, as well as stricter laws on animal testing, may further stymie the market.

Furthermore, a lack of infrastructure may make it difficult to transfer medicines and vaccines to where they are needed due to poor transportation links, a lack of refrigeration, and a lack of laboratory networks for conducting health checks. Changes in purchasing behaviors, increased generic pharmaceuticals, low-cost human medication sublimities, and regulatory restrictions are critical variables that could severely limit market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Key Market Trends

Laser Therapy is expected to grow at a healthy rate during the forecast period

Laser therapy is used to treat both chronic and acute injuries, as well as arthritis, sprains, and strains, edema caused by back disc disorders, and muscular-skeletal abnormalities. It also aids in the regeneration of nerve tissue following surgery. The most prevalent laser therapy is the therapeutic laser treatment of osteoarthritis (OA) in dogs and cats. In osteoarthritis (OA), the laser intensity should be 8-10 J/cm2. Due to the inflammation associated with the illness, laser therapy may potentially benefit tendonitis.

By adjusting the degree of emission, some laser systems can be utilized for both surgical and therapeutic reasons. Among the laser therapy brands available for veterinary pain management are B-Cure Laser, TENDLITE, Lumasoothe, iReliev, Keebomed, and MLS Laser Therapy (ASAveterinary). Product launches, collaborations, expansions, and mergers were among the techniques used by market participants.

It is a 28-watt diode-based laser with the unusual feature of mixing four separate wavelengths, which can also be regulated independently. Because of the causes, the category is predicted to increase significantly over the forecast period.

Regional Insights

Over the forecast period, the North American region is expected to grow significantly.

The United States, as part of the North American region, is predicted to see considerable market expansion as a result of factors such as expanding pet adoption and rising per capita animal healthcare expenditure.

The increase in the number of veterinarians worldwide is expected to drive present and future market growth for veterinary pain management medications throughout the forecast period. Furthermore, highly developed, and well-established animal healthcare facilities are propelling expansion.

Veterinary pain management is a very important aspect of veterinary therapeutics. Animals suffer from pain, sometimes chronic, but however are unable to express it. Pain in animals could be associated with surgical pain, arthritis and cancer. Prevalence of chronic pain in animals is also known as “getting old” or slowing down”.

This could hamper the productivity of both farm and pet animals and their temper too. Research on reducing chronic pain in animals in ongoing leading to availability of multiple options to treat the various causes of pain in animals including pain medications, physical rehabilitation, acupuncture, laser therapy, and therapeutic massage to cite a few.

A few signs of pets in pain are reluctance to walk on slippery surfaces, frequently going up/down the stairs, selective behaviour and attempting to stand up with front legs. Others include loss of appetite, aggression, reduced activity and tail flicking.

Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Veterinary Pain Management Drugs Market: Drivers and Restraints

Growing urbanization and increasing spread of isolated family units is leading to humanization of animals. Adoption of pets as companions has been increasing globally, driving the need for medicines, preventive treatments and care facilities for companion animals. Furthermore, increasing tendency to overfeed pets has been resulting in increasing obesity in pets globally.

This has been negatively impacting the health of pets, thus making them susceptible to more pain-related diseases, accelerated ageing - hence driving the demand for pain medicines.

A marked shift towards maintaining animal health and welfare has been recorded in developing countries and popularity of compounded drugs has been growing rapidly due to need for easy access to services and affordable veterinary drugs. This contributes to development of better personalized drugs which generally have higher efficacy.

Barriers include people’s lack of awareness regarding certain serious companion animal diseases as opposed to livestock diseases, which are more regularly monitored.

This phenomenon is particularly noted in many developing countries. High costs of development of new drugs, longer approval times, declining incremental innovation in veterinary therapeutics and declining R&D spend may hamper the veterinary pain management market over forecast period.

Veterinary Pain Management Drugs Market: Overview

Global veterinary pain management drugs market is undergoing significant changes due to the increased priority for the pain management within veterinary fraternity.

Furthermore several companies in the market place creating awareness by means of Continuous Medical Education (CME) in veterinary pain management, this may change the market dynamics over a given period of forecast. By drug type, sub segment such as opioids and NSIDs in the global veterinary pain management drugs market are expected to grow in positive traction owing to its owing to its affordability availability and efficacy in treating the pain.

Veterinary Pain Management Drugs Market: Region-wise Outlook

Geographically, veterinary pain management drugs market  is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe will remain key markets for veterinary pain management drugs market due to deeper market penetration of the products and strong presence of big players in the market moreover, increasing awareness among farm owner, pet owners about the pain management in the regions.

Asia Pacific is anticipated to register positive growth owing to increased large number of animal pool and increasing trend of animal/pets adopting in the region.

Veterinary Pain Management Drugs Market: Key Players

Some of the players in the Global Veterinary Pain Management Drugs market are Boehringer Ingelheim, Merck & Co., Inc., Zoetis, Elanco, Bayer Pharma AG, Ceva Sante Animale and Norbrook Laboratories to name a few.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil and Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Veterinary Pain Management Drugs Market: Segmentation

Global veterinary pain management drugs market has been segmented on the basis of drug type, route of administration, end user and region.

Based on the Drug type, the global veterinary pain management drugs market is segmented into the following:

  • Opioids
  • Morphine
  • Hydromorphone
  • Codeine
  • α2-adrenergic Agonists
  • Xylazine
  • Medetomidine
  • Local Anesthetics
  • Bupivacaine
  • Lidocaine
  • Chloroprocaine
  • Nonsteroidal Anti-inflammatory Drugs (NSIDs)
  • Etodolac
  • Fentanyl
  • Meloxicam
  • Sedatives
  • Corticosteroids

Based on the Route of Administration, the global veterinary pain management drugs market is segmented into the following:

  • Oral Preparations
  • Parenteral Preparations

Based on the end user, the global veterinary pain management drugs market is segmented into the following:

  • Veterinary Hospital Pharmacies
  • Retail Veterinary Pharmacies
  • Online Pharmacies

Frequently Asked Questions

The market is likely to register a CAGR of 7.2% through 2032.

The market is currently valued at US$ 1.37 Bn in 2022.

The market is likely to grow to a valuation of US$ 2.79 Bn by 2032.

North America is likely to be a leading market during the forecast period.

Table of Content


Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables


Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts


Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Veterinary Pain Management Drugs Market